Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$6,514,076
+$244,435 QoQ
Shares Held
25,649
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.91%
of 13F equity value
Holder Rank
#1,415
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 69%
Shared 0%
None 31%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Argyle Capital Management, LLC holds $43,679,401 across 8 Drug Manufacturers - General names. JNJ ranks #4 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,767 | $12,914,263 | |
| 2 | MRK |
Merck & Co., Inc.
|
62,540 | $8,036,390 | |
| 3 | AMGN |
Amgen Inc
|
19,501 | $7,061,702 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
25,649 | $6,514,076 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
72,282 | $4,164,888 | |
| 6 | PFE |
Pfizer Inc
|
155,636 | $3,747,714 | |
| 7 | ABBV |
AbbVie Inc.
|
3,450 | $868,158 | |
| 8 | NVS |
Novartis AG
|
2,375 | $372,210 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,514,076 | 25,649 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $6,269,641 | 25,649 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $5,360,832 | 25,904 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $4,803,119 | 25,904 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $3,956,836 | 25,904 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $4,312,503 | 26,004 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $3,731,774 | 25,804 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $3,909,211 | 24,122 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $3,621,260 | 24,776 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $3,763,498 | 23,791 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $3,634,957 | 23,191 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $4,394,642 | 28,216 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $4,670,312 | 28,216 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $4,692,315 | 30,273 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $5,347,725 | 30,273 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $4,961,733 | 30,373 | Shares | Sole | 2022-10-21 | |
| 2022-06-30 | $5,391,511 | 30,373 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $5,383,006 | 30,373 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $5,349,872 | 31,273 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $5,171,714 | 32,023 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $5,304,298 | 32,198 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $5,330,034 | 32,431 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $5,115,794 | 32,506 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $5,029,315 | 33,781 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $4,924,581 | 35,018 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $4,591,910 | 35,018 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||